Casma Therapeutics is Drug Discovery in United States that focus on invading pathogens business. Founded in 2018. They cover business area such as developer, autophagy, new target area, drug discovery, development, unwanted protein, organelle, invading pathogen, lysosomal storage disorder, muscle disorder, inflammatory disorder, neurodegeneration, physician, unmet medical need, cure, patient, serious disease.
2018
( 6 years old in 2024 )
Invading Pathogens
-
400 Technology Square
Suite 201
Cambridge, MA 02139
United States
Private
developerautophagynew target areadrug discoverydevelopmentunwanted proteinorganelleinvading pathogenlysosomal storage disordermuscle disorderinflammatory disorderneurodegenerationphysicianunmet medical needcurepatientserious disease
* We use standard office opening hours in near Casma Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Casma Therapeutics is Drug Discovery business from United States that founded in 2018 (6 years old in 2024), Casma Therapeutics business is focusing on Invading Pathogens.
Casma Therapeutics headquarter office and corporate office address is located in 400 Technology Square Suite 201 Cambridge, MA 02139 United States.
Casma Therapeutics was founded in United States.
In 2024, Casma Therapeutics is currently focus on invading pathogens sector.
Above is snippet of Google Trends for "invading pathogens" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Casma Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
